StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Interpace Biosciences's enterprise value was $135.82M on Oct 19, 2026, against $4.01M a year earlier. Over the last 2 years it ranged from $1.75M to $207.01M, with a median of $5.85M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$135.82M+3274.3%
2025Dec 31, 2025$4.02M-61.6%
2024Dec 31, 2024$10.48M–

More Interpace Biosciences figures

See a number that looks wrong?